Investor Moves
| Name | Value | Action | Change | Price | Current Price |
|---|---|---|---|---|---|
Ken GriffinCitadel Advisors $-43.3K ExitQ1 2026 $43k -- $0.164 | |||||
News
globenewswire.comLiminatus Pharma Enters Into Warrant Exercise Transaction for $1.9 Million in Gross Proceedsglobenewswire.comJun 3
globenewswire.comLiminatus Pharma Announces Nasdaq Delisting Notificationglobenewswire.comMay 21
globenewswire.comLiminatus Pharma Announces Nasdaq Delisting Notificationglobenewswire.comMay 21
feeds.benzinga.comLiminatus Pharma Is Trending Overnight — Here's Why LIMN Stock Surged Over 79% In After-Hours Sessionfeeds.benzinga.comMay 21
defenseworld.netAthira Pharma (NASDAQ:LONA) and Liminatus Pharma (NASDAQ:LIMN) Head to Head Analysisdefenseworld.netMar 21